Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

521
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
521
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

534
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
534
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

415
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
415
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

461
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
461
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

439
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
439
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

244
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
244

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology and Clinical Outcome of Common Multi-drug Resistant Gram-negative Bacterial Infections in a Network of Hospitals in India (IMPRES): A Multicenter Intensive Care Unit-based Prospective Clinical Study.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2025
Same author

The HScore to Diagnose HLH in Scrub Typhus: Overdiagnosis or under Diagnosis and Does It Really Matter?

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2024
Same author

ISCCM Position Statement on the Management of Severe Malaria in Intensive Care Unit.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2024
Same author

Guidelines for Antibiotics Prescription in Critically Ill Patients.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2024
Same author

ISCCM Position Statement: Management of Severe Dengue in Intensive Care Unit.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2024
Same author

Risk of Bleeding in Dengue: Making Predictions is Difficult Especially about the Future.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2023

Related Experiment Video

Updated: Oct 25, 2025

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging
09:04

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging

Published on: June 8, 2017

6.7K

Malaria in the Intensive Care Unit.

Ashit Hegde1

  • 1Department of Critical Care Medicine, PD Hinduja National Hospital and Medical Research Centre Hospital, Mumbai, Maharashtra, India.

Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine
|August 4, 2021
PubMed
Summary
This summary is machine-generated.

Severe malaria, primarily from Plasmodium falciparum, requires prompt diagnosis and parenteral artesunate treatment. Management focuses on supportive care, with artesunate now recommended for all trimesters of pregnancy.

Keywords:
Falciparum malariaMalaria in pregnancyMalaria intensive careSevere malariaSevere vivax malaria

More Related Videos

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.3K
A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting
07:27

A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting

Published on: May 16, 2013

18.9K

Related Experiment Videos

Last Updated: Oct 25, 2025

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging
09:04

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging

Published on: June 8, 2017

6.7K
In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.3K
A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting
07:27

A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting

Published on: May 16, 2013

18.9K

Area of Science:

  • Infectious Diseases
  • Tropical Medicine
  • Critical Care Medicine

Background:

  • Severe malaria, predominantly caused by Plasmodium falciparum, is a critical condition characterized by organ dysfunction.
  • Diagnosis relies on peripheral smear examination and rapid diagnostic tests.
  • The increasing recognition of Plasmodium vivax as a cause of severe malaria warrants further investigation into its virulence.

Purpose of the Study:

  • To review the current understanding and management strategies for severe malaria, including Plasmodium falciparum and Plasmodium vivax infections.
  • To highlight the role of parenteral artesunate as the primary treatment and discuss supportive care measures.
  • To address specific considerations for malaria in pregnancy and the evolving role of interventions like exchange transfusions.

Main Methods:

  • Review of current literature and clinical guidelines on severe malaria management.
  • Discussion of diagnostic modalities, including microscopy and rapid diagnostic tests.
  • Analysis of treatment protocols, focusing on parenteral artesunate and Artemisinin-based Combination Therapy (ACT).

Main Results:

  • Parenteral artesunate is the established first-line treatment for severe malaria, followed by ACT.
  • Supportive care is crucial for managing complications; the utility of exchange transfusions is debated.
  • Artesunate is recommended for severe malaria in all trimesters of pregnancy.
  • Severe Plasmodium vivax malaria is increasingly observed, with similar management to severe Plasmodium falciparum malaria.

Conclusions:

  • Prompt diagnosis and parenteral artesunate followed by ACT are essential for managing severe malaria.
  • Supportive care remains paramount for complications, while the role of exchange transfusion is questionable.
  • Severe malaria in pregnancy requires specific attention, with artesunate as the drug of choice.
  • The rising incidence and virulence of severe Plasmodium vivax malaria necessitate further research.